₹ 893.64 Cr
2.25%
Nifty Pharma TRI
INF277K016A9
5000.0
1000.0
500
Meeta Shetty
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
Tata India Pharma & Healthcare Fund-Regular Plan-Growth | 51.54 | 15.51 | 23.56 |
Nifty Pharma TRI | 52.87 | 11.28 | 18.17 |
Equity
Debt
Others
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Company | Holdings (%) |
---|---|
Sun Pharmaceutical Industries Ltd. | 13.52 |
Aurobindo Pharma Ltd. | 9.56 |
Lupin Ltd. | 9.4 |
Dr. Reddy's Laboratories Ltd. | 7.47 |
Cipla Ltd. | 6.5 |
Zydus Lifesciences Ltd. | 5.03 |
Divi's Laboratories Ltd. | 4.7 |
Fortis Healthcare Ltd. | 4.2 |
Apollo Hospitals Enterprise Ltd. | 3.92 |
Alkem Laboratories Ltd. | 3.8 |
Sector | Holdings (%) |
---|---|
Healthcare | 94.02 |
Services | 2.39 |
Others | 2.29 |
Chemicals | 1.3 |
N/A | 0.0 |
Scheme Name | 5Y (%) |
---|---|
Tata India Pharma & Healthcare Reg Gr | 23.56 |
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum | 25.77 |
ABSL Pharma and Healthcare Reg Gr | 0.0 |
SBI HEALTHCARE Opportunities Reg Gr | 24.87 |
Nippon India Pharma Fund Gr Gr | 24.41 |
UTI Healthcare Reg Gr | 22.44 |
DSP Healthcare Reg Gr | 27.19 |
Mirae Asset Healthcare Reg Gr | 25.04 |
LIC MF Healthcare Fund Reg Gr | 19.52 |
ITI Pharma and Healthcare Fund Reg Gr | 0.0 |